Inhibition of hyperlipogenesis with puromycin or actinomycin D.
D000818:Animals; D002849:Chromatography, Gas; D003065:Coenzyme A / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology*; D005227:Fatty Acids / Q000096:biosynthesis*; D066298:In Vitro Techniques; D008025:Ligases / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D011691:Puromycin / Q000494:pharmacology*; D051381:Rats
D005227:Fatty Acids; D003609:Dactinomycin; D011691:Puromycin; D009249:NADP; D008025:Ligases; D003065:Coenzyme A